The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain signals, testing the implant’s feasibility for assistive technology. . . . → Read More: Trial Underway Testing Brain-Computer Implant
|
|||||
|
|
An Indiana company is receiving U.S. government and private grants to develop a solar-powered algorithm-controlled crop dehydrator for small farms. . . . → Read More: Smart Solar Powered Crop Dryer Receives Grant Funds 
Results from a small clinical trial show a treatment for Alzheimer’s disease using radio waves is safe and offers early evidence it can reverse memory loss. . . . → Read More: Trial Shows Radio Waves Safe for Alzheimer’s Therapy 
A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells. . . . → Read More: Gel, Crispr Help Defeat Cancer Drug Obstacles 
A grant from National Institutes of Health is funding a system using augmented reality and holography to improve minimally-invasive repair of blood vessels. . . . → Read More: NIH Funds Augmented-Reality Endovascular System 
Results of a small-scale clinical trial show an experimental treatment using an injectable gel to repair damage from a heart attack is safe for patients. . . . → Read More: Hydrogel Shown Safe to Repair Heart Damage 
Apple Inc. plans to release a new medical research app and announced a series of studies for its use in women’s health, hearing, and heart health. . . . → Read More: New App for Medical Research, Studies Revealed 
A drug candidate designed to compensate for damage to brain cells from toxic proteins prevented nerve cell damage and memory loss in lab mice. . . . → Read More: Experimental Drug Shown to Prevent Memory Loss 
Results of a clinical trial show a treatment targeting specific genetic aberrations produces a therapeutic response in most patients with lung cancer from that condition. . . . → Read More: Response by Patients Shown to Precision Lung Cancer Drug 
A company spun-off from biomedical engineering labs at Harvard University is acquiring research on microbial communities in elite athletes to create new probiotics. . . . → Read More: Spin-Off Licensing Athletic Microbiome Technology  Comments are closed  Intellectual property, New products  biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, university |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||